China Biologic Products Holdings, Inc. (CBPO) Financial Statements (2024 and earlier)

Company Profile

Business Address 18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING, 100125
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2017
MRQ
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 183,766182,97080,820144,138129,609
Cash and cash equivalents 183,766144,93880,820144,138129,609
Short-term investments  38,033   
Restricted cash and investments   63,678  
Receivables 33,91925,14519,40317,27011,206
Inventory, net of allowances, customer advances and progress billings 156,413126,395101,30588,63575,679
Inventory 156,413126,395101,30588,63575,679
Prepaid expense    7,641
Deposits current assets 1,00010,056   
Prepaid expense and other current assets5,665
Deferred tax assets 3,9543,2253,3462,0651,841
Other undisclosed current assets 14,32121,32111,4364,543(1,841)
Total current assets: 393,372369,113279,987264,293222,160
Noncurrent Assets
Property, plant and equipment 132,092105,36480,23173,14951,325
Long-term investments and receivables 53,86048,55218,22211,35010,537
Long-term investments 10,6158,71818,22211,35010,537
Accounts and financing receivable, after allowance for credit loss 43,24539,834   
Intangible assets, net (including goodwill)    2,5853,542
Intangible assets, net (excluding goodwill)    2,5853,542
Deposits noncurrent assets   12,79213,66714,753
Restricted cash and investments   40,23030,5242,912
Other noncurrent assets 2,2444,8613,475 
Deferred tax assets, net 672    
Other undisclosed noncurrent assets 22,71823,57611,9098,2135,819
Total noncurrent assets: 211,585182,354166,860139,48888,887
TOTAL ASSETS: 604,958551,466446,847403,781311,047
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 13,64314,19313,0868,6487,422
Taxes payable 7,4844,5118,2574,2024,513
Accounts payable 6,1599,6824,8294,4462,909
Debt   84,2039,8227,935
Due to related parties    7,2074,082
Other undisclosed current liabilities 59,79857,46323,39337,76228,281
Total current liabilities: 73,44171,655120,68263,43947,719
Noncurrent Liabilities
Long-term debt and lease obligation   40,00030,000 
Long-term debt, excluding current maturities   40,00030,000 
Liabilities, other than long-term debt 10,38012,84918,6943,3568,562
Deferred revenue and credits 3,7564,5262,7653,0042,912
Deferred tax liabilities, net   7,790(3,016)2,653
Other liabilities 6,6248,3238,1383,3692,997
Other undisclosed noncurrent liabilities   (7,790)3,016(2,653)
Total noncurrent liabilities: 10,38012,84950,90436,3735,909
Total liabilities: 83,82184,505171,58599,81253,628
Equity
Equity, attributable to parent 462,201382,343212,087237,692195,470
Common stock 33333
Treasury stock, value (56,425)(56,425)(76,571)(29,594) 
Additional paid in capital 105,460105,08024,00872,03262,252
Accumulated other comprehensive income (loss) (25,320)(19)19,98521,50614,072
Retained earnings 438,483333,704244,661173,745119,143
Equity, attributable to noncontrolling interest 58,93684,61963,17566,27861,949
Total equity: 521,137466,962275,262303,970257,419
TOTAL LIABILITIES AND EQUITY: 604,958551,466446,847403,781311,047

Income Statement (P&L) ($ in thousands)

6/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues 341,169296,458243,252203,357184,813
Cost of revenue (124,034)(106,483)(80,025)(65,484)(58,836)
Gross profit: 217,135189,975163,226137,873125,977
Operating expenses (73,220)(57,389)(47,171)(52,013)(55,405)
Other operating income, net     571
Other undisclosed operating income (loss)   (4,896)1,0733,346
Operating income: 143,915132,586111,15986,93374,489
Nonoperating income 10,0052,51211,5935,4696,646
Investment income, nonoperating 7,8165,55125,6454,4334,679
Interest and debt expense (254)(1,727)(3,698)(1,135)(1,270)
Other undisclosed income from continuing operations before equity method investments, income taxes   3,6981,1351,270
Income from continuing operations before equity method investments, income taxes: 153,665133,371122,75292,40181,135
Income (loss) from equity method investments 2,519(1,311)8,6462,1702,666
Other undisclosed income (loss) from continuing operations before income taxes (2,265)3,039  (2,666)
Income from continuing operations before income taxes: 153,919135,098131,39894,57281,135
Income tax expense (25,126)(20,993)(26,640)(15,540)(15,163)
Income from continuing operations: 128,793114,106104,75979,03265,972
Income before gain (loss) on sale of properties: 128,793114,106104,75979,03265,972
Other undisclosed net loss   (8,646)(2,170) 
Net income: 128,793114,10696,11376,86165,972
Net loss attributable to noncontrolling interest (24,014)(25,063)(25,196)(22,260)(20,750)
Net income attributable to parent: 104,77989,04370,91754,60245,222
Other undisclosed net loss available to common stockholders, basic (2,987)(2,071)(1,211)(456)(70)
Net income available to common stockholders, basic: 101,79286,97269,70654,14545,153
Other undisclosed net loss available to common stockholders, diluted     (1,769)
Net income available to common stockholders, diluted: 101,79286,97269,70654,14543,383

Comprehensive Income ($ in thousands)

6/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income: 128,793114,10696,11376,86165,972
Other undisclosed comprehensive income (loss) (31,303)(24,368)(1,919)9,1261,735
Comprehensive income: 97,49089,73794,19485,98767,707
Comprehensive income (loss), net of tax, attributable to noncontrolling interest (19,027)(20,698)(24,798)23,95221,164
Other undisclosed comprehensive loss, net of tax, attributable to parent    (47,903)(42,327)
Comprehensive income, net of tax, attributable to parent: 78,46469,03969,39662,03646,544

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: